FIRST REGULAR SESSION

SENATE BILL NO. 503

90TH GENERAL ASSEMBLY


INTRODUCED BY SENATOR HOWARD.

Read 1st time March 1, 1999, and 1,000 copies ordered printed.



TERRY L. SPIELER, Secretary.

S2169.01I


AN ACT

To repeal sections 195.050, 337.015 and 338.010, RSMo 1994, and sections 195.010, 195.100, 195.110, 195.204 and 195.400, RSMo Supp. 1998, relating to psychologists, and to enact in lieu thereof nine new sections relating to the same subject.


Be it enacted by the General Assembly of the State of Missouri, as follows:

Section A.  Sections 195.050, 337.015 and 338.010, RSMo 1994, and sections 195.010, 195.100, 195.110, 195.204 and 195.400, RSMo Supp. 1998, are repealed and nine new sections enacted in lieu thereof, to be known as sections 195.010, 195.050, 195.100, 195.110, 195.204, 195.400, 337.015, 337.053 and 338.010, to read as follows:

195.010.  The following words and phrases as used in sections 195.005 to 195.425, unless the context otherwise requires, mean:

(1)  "Addict", a person who habitually uses one or more controlled substances to such an extent as to create a tolerance for such drugs, and who does not have a medical need for such drugs, or who is so far addicted to the use of such drugs as to have lost the power of self-control with reference to his addiction;

(2)  "Administer", to apply a controlled substance, whether by injection, inhalation, ingestion, or any other means, directly to the body of a patient or research subject by:

(a)  A practitioner (or, in his presence, by his authorized agent); or

(b)  The patient or research subject at the direction and in the presence of the practitioner;

(3)  "Agent", an authorized person who acts on behalf of or at the direction of a manufacturer, distributor, or dispenser.  The term does not include a common or contract carrier, public warehouseman, or employee of the carrier or warehouseman while acting in the usual and lawful course of the carrier's or warehouseman's business;

(4)  "Attorney for the state", any prosecuting attorney, circuit attorney, or attorney general authorized to investigate, commence and prosecute an action under sections 195.005 to 195.425;

(5)  "Controlled substance", a drug, substance, or immediate precursor in Schedules I through V listed in [this] sections 195.005 to 195.425;

(6)  "Controlled substance analogue", a substance the chemical structure of which is substantially similar to the chemical structure of a controlled substance in Schedule I or II and:

(a)  Which has a stimulant, depressant, or hallucinogenic effect on the central nervous system substantially similar to the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance included in Schedule I or II; or

(b)  With respect to a particular individual, which that individual represents or intends to have a stimulant, depressant, or hallucinogenic effect on the central nervous system substantially similar to the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance included in Schedule I or II.  The term does not include a controlled substance; any substance for which there is an approved new drug application; any substance for which an exemption is in effect for investigational use, for a particular person, under Section 505 of the federal Food, Drug and Cosmetic Act (21 U.S.C. 355) to the extent conduct with respect to the substance is pursuant to the exemption; or any substance to the extent not intended for human consumption before such an exemption takes effect with respect to the substance;

(7)  "Counterfeit substance", a controlled substance which, or the container or labeling of which, without authorization, bears the trademark, trade name, or other identifying mark, imprint, number or device, or any likeness thereof, of a manufacturer, distributor, or dispenser other than the person who in fact manufactured, distributed, or dispensed the substance;

(8)  "Deliver" or "delivery", the actual, constructive, or attempted transfer from one person to another of drug paraphernalia or of a controlled substance, or an imitation controlled substance, whether or not there is an agency relationship, and includes a sale;

(9)  "Dentist", a person authorized by law to practice dentistry in this state;

(10)  "Depressant or stimulant substance":

(a)  A drug containing any quantity of barbituric acid or any of the salts of barbituric acid or any derivative of barbituric acid which has been designated by the United States Secretary of Health and Human Services as habit forming under 21 U.S.C. 352(d);

(b)  A drug containing any quantity of:

a.  Amphetamine or any of its isomers;

b.  Any salt of amphetamine or any salt of an isomer of amphetamine; or

c.  Any substance the United States Attorney General, after investigation, has found to be, and by regulation designated as, habit forming because of its stimulant effect on the central nervous system;

(c)  Lysergic acid diethylamide; or

(d)  Any drug containing any quantity of a substance that the United States Attorney General, after investigation, has found to have, and by regulation designated as having, a potential for abuse because of its depressant or stimulant effect on the central nervous system or its hallucinogenic effect;

(11)  "Dispense", to deliver a narcotic or controlled dangerous drug to an ultimate user or research subject by or pursuant to the lawful order of a practitioner including the prescribing, administering, packaging, labeling, or compounding necessary to prepare the substance for such delivery.  "Dispenser" means a practitioner who dispenses;

(12)  "Distribute", to deliver other than by administering or dispensing a controlled substance;

(13)  "Distributor", a person who distributes;

(14)  "Drug":

(a)  Substances recognized as drugs in the official United States Pharmacopoeia, Official Homeopathic Pharmacopoeia of the United States, or Official National Formulary, or any supplement to any of them;

(b)  Substances intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in humans or animals;

(c)  Substances, other than food, intended to affect the structure or any function of the body of humans or animals; and

(d)  Substances intended for use as a component of any article specified in this subdivision.  It does not include devices or their components, parts or accessories;

(15)  "Drug-dependent person", a person who is using a controlled substance and who is in a state of psychic or physical dependence, or both, arising from the use of such substance on a continuous basis.  Drug dependence is characterized by behavioral and other responses which include a strong compulsion to take the substance on a continuous basis in order to experience its psychic effects or to avoid the discomfort caused by its absence;

(16)  "Drug enforcement agency", the Drug Enforcement Administration in the United States Department of Justice, or its successor agency;

(17)  "Drug paraphernalia", all equipment, products and materials of any kind which are used, intended for use, or designed for use, in planting, propagating, cultivating, growing, harvesting, manufacturing, compounding, converting, producing, processing, preparing, storing, containing, concealing, injecting, ingesting, inhaling, or otherwise introducing into the human body a controlled substance or an imitation controlled substance in violation of sections 195.005 to 195.425.  It includes, but is not limited to:

(a)  Kits used, intended for use, or designed for use in planting, propagating, cultivating, growing or harvesting of any species of plant which is a controlled substance or from which a controlled substance can be derived;

(b)  Kits used, intended for use, or designed for use in manufacturing, compounding, converting, producing, processing, or preparing controlled substances or imitation controlled substances;

(c)  Isomerization devices used, intended for use, or designed for use in increasing the potency of any species of plant which is a controlled substance or an imitation controlled substance;

(d)  Testing equipment used, intended for use, or designed for use in identifying, or in analyzing the strength, effectiveness or purity of controlled substances or imitation controlled substances;

(e)  Scales and balances used, intended for use, or designed for use in weighing or measuring controlled substances or imitation controlled substances;

(f)  Dilutents and adulterants, such as quinine hydrochloride, mannitol, mannite, dextrose and lactose, used, intended for use, or designed for use in cutting controlled substances or imitation controlled substances;

(g)  Separation gins and sifters used, intended for use, or designed for use in removing twigs and seeds from, or in otherwise cleaning or refining, marijuana;

(h)  Blenders, bowls, containers, spoons and mixing devices used, intended for use, or designed for use in compounding controlled substances or imitation controlled substances;

(i)  Capsules, balloons, envelopes and other containers used, intended for use, or designed for use in packaging small quantities of controlled substances or imitation controlled substances;

(j)  Containers and other objects used, intended for use, or designed for use in storing or concealing controlled substances or imitation controlled substances;

(k)  Hypodermic syringes, needles and other objects used, intended for use, or designed for use in parenterally injecting controlled substances or imitation controlled substances into the human body;

(l)  Objects used, intended for use, or designed for use in ingesting, inhaling, or otherwise introducing marijuana, cocaine, hashish, or hashish oil into the human body, such as:

a.  Metal, wooden, acrylic, glass, stone, plastic, or ceramic pipes with or without screens, permanent screens, hashish heads, or punctured metal bowls;

b.  Water pipes;

c.  Carburetion tubes and devices;

d.  Smoking and carburetion masks;

e.  Roach clips meaning objects used to hold burning material, such as a marijuana cigarette, that has become too small or too short to be held in the hand;

f.  Miniature cocaine spoons and cocaine vials;

g.  Chamber pipes;

h.  Carburetor pipes;

i.  Electric pipes;

j.  Air-driven pipes;

k.  Chillums;

l.  Bongs;

m.  Ice pipes or chillers;

In determining whether an object is drug paraphernalia, a court or other authority should consider, in addition to all other logically relevant factors, the following:

(a)  Statements by an owner or by anyone in control of the object concerning its use;

(b)  Prior convictions, if any, of an owner, or of anyone in control of the object, under any state or federal law relating to any controlled substance or imitation controlled substance;

(c)  The proximity of the object, in time and space, to a direct violation of sections 195.005 to 195.425;

(d)  The proximity of the object to controlled substances or imitation controlled substances;

(e)  The existence of any residue of controlled substances or imitation controlled substances on the object;

(f)  Direct or circumstantial evidence of the intent of an owner, or of anyone in control of the object, to deliver it to persons who he knows, or should reasonably know, intend to use the object to facilitate a violation of sections 195.005 to 195.425; the innocence of an owner, or of anyone in control of the object, as to direct violation of sections 195.005 to 195.425 shall not prevent a finding that the object is intended for use, or designed for use as drug paraphernalia;

(g)  Instructions, oral or written, provided with the object concerning its use;

(h)  Descriptive materials accompanying the object which explain or depict its use;

(i)  National or local advertising concerning its use;

(j)  The manner in which the object is displayed for sale;

(k)  Whether the owner, or anyone in control of the object, is a legitimate supplier of like or related items to the community, such as a licensed distributor or dealer of tobacco products;

(l)  Direct or circumstantial evidence of the ratio of sales of the object to the total sales of the business enterprise;

(m)  The existence and scope of legitimate uses for the object in the community;

(n)  Expert testimony concerning its use;

(18)  "Federal narcotic laws", the laws of the United States relating to controlled substances;

(19)  "Hospital", a place devoted primarily to the maintenance and operation of facilities for the diagnosis, treatment or care, for not less than twenty-four hours in any week, of three or more nonrelated individuals suffering from illness, disease, injury, deformity or other abnormal physical conditions; or a place devoted primarily to provide, for not less than twenty-four consecutive hours in any week, medical or nursing care for three or more nonrelated individuals.  The term "hospital" does not include convalescent, nursing, shelter or boarding homes as defined in chapter 198, RSMo;

(20)  "Immediate precursor", a substance which:

(a)  The state department of health has found to be and by rule designates as being the principal compound commonly used or produced primarily for use in the manufacture of a controlled substance;

(b)  Is an immediate chemical intermediary used or likely to be used in the manufacture of a controlled substance; and

(c)  The control of which is necessary to prevent, curtail or limit the manufacture of the controlled substance;

(21)  "Imitation controlled substance", a substance that is not a controlled substance, which by dosage unit appearance (including color, shape, size and markings), or by representations made, would lead a reasonable person to believe that the substance is a controlled substance.  In determining whether the substance is an "imitation controlled substance" the court or authority concerned should consider, in addition to all other logically relevant factors, the following:

(a)  Whether the substance was approved by the federal Food and Drug Administration for over-the-counter (nonprescription or nonlegend) sales and was sold in the federal Food and Drug Administration approved package, with the federal Food and Drug Administration approved labeling information;

(b)  Statements made by an owner or by anyone else in control of the substance concerning the nature of the substance, or its use or effect;

(c)  Whether the substance is packaged in a manner normally used for illicit controlled substances;

(d)  Prior convictions, if any, of an owner, or anyone in control of the object, under state or federal law related to controlled substances or fraud;

(e)  The proximity of the substances to controlled substances;

(f)  Whether the consideration tendered in exchange for the noncontrolled substance substantially exceeds the reasonable value of the substance considering the actual chemical composition of the substance and, where applicable, the price at which over-the-counter substances of like chemical composition sell.  An imitation controlled substance does not include a placebo or registered investigational drug either of which was manufactured, distributed, possessed or delivered in the ordinary course of professional practice or research;

(22)  "Laboratory", a laboratory approved by the department of health as proper to be entrusted with the custody of controlled substances but does not include a pharmacist who compounds controlled substances to be sold or dispensed on prescriptions;

(23)  "Manufacture", the production, preparation, propagation, compounding or processing of drug paraphernalia or of a controlled substance, or an imitation controlled substance, either directly or by extraction from substances of natural origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis, and includes any packaging or repackaging of the substance or labeling or relabeling of its container.  This term does not include the preparation or compounding of a controlled substance or an imitation controlled substance or the preparation, compounding, packaging or labeling of a narcotic or dangerous drug:

(a)  By a practitioner as an incident to his administering or dispensing of a controlled substance or an imitation controlled substance in the course of his professional practice, or

(b)  By a practitioner or his authorized agent under his supervision, for the purpose of, or as an incident to, research, teaching or chemical analysis and not for sale;

(24)  "Marijuana", all parts of the plant genus Cannabis in any species or form thereof, including, but not limited to Cannabis Sativa L., Cannabis Indica, Cannabis Americana, Cannabis Ruderalis, and Cannabis Gigantea, whether growing or not, the seeds thereof, the resin extracted from any part of the plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds or resin.  It does not include the mature stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture or preparation of the mature stalks (except the resin extracted therefrom), fiber, oil or cake, or the sterilized seed of the plant which is incapable of germination;

(25)  "Narcotic drug", any of the following, whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical analysis:

(a)  Opium, opiate, and any derivative, of opium or opiate, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of the isomers, esters, ethers, and salts is possible within the specific chemical designation.  The term does not include the isoquinoline alkaloids of opium;

(b)  Coca leaves, but not including extracts of coca leaves from which cocaine, ecgonine, and derivatives of ecgonine or their salts have been removed;

(c)  Cocaine or any salt, isomer, or salt of isomer thereof;

(d)  Ecgonine, or any derivative, salt, isomer, or salt of isomer thereof;

(e)  Any compound, mixture, or preparation containing any quantity of any substance referred to in paragraphs (a) to (d) of this subdivision;

(26)  "Official written order", an order written on a form provided for that purpose by the United States Commissioner of Narcotics, under any laws of the United States making provision therefor, if such order forms are authorized and required by federal law, and if no such order form is provided, then on an official form provided for that purpose by the department of health;

(27)  "Opiate", any substance having an addiction-forming or addiction-sustaining liability similar to morphine or being capable of conversion into a drug having addiction-forming or addiction-sustaining liability.  The term includes its racemic and levorotatory forms.  It does not include, unless specifically controlled under section 195.017, the dextrorotatory isomer of 3-methoxy-n-methyl-morphinan and its salts (dextromethorphan);

(28)  "Opium poppy", the plant of the species Papaver somniferum L., except its seeds;

(29)  "Person", an individual, corporation, government or governmental subdivision or agency, business trust, estate, trust, partnership, joint venture, association, or any other legal or commercial entity;

(30)  "Pharmacist", a licensed pharmacist as defined by the laws of this state, and where the context so requires, the owner of a store or other place of business where controlled substances are compounded or dispensed by a licensed pharmacist; but nothing in sections 195.005 to 195.425 shall be construed as conferring on a person who is not registered nor licensed as a pharmacist any authority, right or privilege that is not granted to him by the pharmacy laws of this state;

(31)  "Poppy straw", all parts, except the seeds, of the opium poppy, after mowing;

(32)  "Possessed" or "possessing a controlled substance", a person, with the knowledge of the presence and nature of a substance, has actual or constructive possession of the substance.  A person has actual possession if he has the substance on his person or within easy reach and convenient control.  A person who, although not in actual possession, has the power and the intention at a given time to exercise dominion or control over the substance either directly or through another person or persons is in constructive possession of it.  Possession may also be sole or joint.  If one person alone has possession of a substance possession is sole.  If two or more persons share possession of a substance, possession is joint;

(33)  "Practitioner", a physician, dentist, optometrist, podiatrist, psychologist, veterinarian, scientific investigator, pharmacy, hospital or other person licensed, registered or otherwise permitted by this state to distribute, dispense, conduct research with respect to or administer or to use in teaching or chemical analysis, a controlled substance in the course of professional practice or research in this state, or a pharmacy, hospital or other institution licensed, registered, or otherwise permitted to distribute, dispense, conduct research with respect to or administer a controlled substance in the course of professional practice or research;

(34)  "Production", includes the manufacture, planting, cultivation, growing, or harvesting of drug paraphernalia or of a controlled substance or an imitation controlled substance;

(35)  "Registry number", the number assigned to each person registered under the federal controlled substances laws;

(36)  "Sale", includes barter, exchange, or gift, or offer therefor, and each such transaction made by any person, whether as principal, proprietor, agent, servant or employee;

(37)  "State" when applied to a part of the United States, includes any state, district, commonwealth, territory, insular possession thereof, and any area subject to the legal authority of the United States of America;

(38)  "Ultimate user", a person who lawfully possesses a controlled substance or an imitation controlled substance for his own use or for the use of a member of his household or for administering to an animal owned by him or by a member of his household;

(39)  "Wholesaler", a person who supplies drug paraphernalia or controlled substances or imitation controlled substances that he himself has not produced or prepared, on official written orders, but not on prescriptions.

195.050.  1.  A duly registered manufacturer or wholesaler may sell controlled substances to any of the following persons:

(1)  To a manufacturer, wholesaler, or pharmacy;

(2)  To a physician, dentist, podiatrist, psychologist or veterinarian;

(3)  To a person in charge of a hospital, but only for use in that hospital;

(4)  To a person in charge of a laboratory, but only for use in that laboratory for scientific and medical purposes.

2.  A duly registered manufacturer or wholesaler may sell controlled substances to any of the following persons:

(1)  On a special written order accompanied by a certificate of exemption, as required by federal laws, to a person in the employ of the United States government or of any state, territorial, district, county, municipal or insular government, purchasing, receiving, possessing, or dispensing controlled substances by reason of his official duties;

(2)  To a master of a ship or person in charge of any aircraft upon which no physician is regularly employed, for the actual medical needs of persons on board such ship or aircraft, when not in port; provided, such controlled substances shall be sold to the master of such ship or person in charge of such aircraft only in pursuance of a special order form approved by a commissioned medical officer or acting surgeon of the United States Public Health Service;

(3)  To a person in a foreign country if the provisions of federal laws are complied with.

3.  An official written order for any controlled substance listed in Schedules I and II shall be signed in duplicate by the person giving the order or by his duly authorized agent.  The original shall be presented to the person who sells or dispenses the controlled substance named therein.  In event of the acceptance of such order by the person, each party to the transaction shall preserve his copy of such order for a period of two years in such a way as to be readily accessible for inspection by any public officer or employee engaged in the enforcement of sections 195.005 to 195.425.  It shall be deemed a compliance with this subsection if the parties to the transaction have complied with federal laws, respecting the requirements governing the use of order forms.

4.  Possession of or control of controlled substances obtained as authorized by this section shall be lawful if in the regular course of business, occupation, profession, employment, or duty of the possessor.

5.  A person in charge of a hospital or of a laboratory, or in the employ of this state or of any other state, or of any political subdivision thereof, and a master or other proper officer of a ship or aircraft, who obtains controlled substances under the provisions of this section or otherwise, shall not administer, nor dispense, nor otherwise use such drugs, within this state, except within the scope of his employment or official duty, and then only for scientific or medicinal purposes and subject to the provisions of sections 195.005 to 195.425.

6.  Every person registered to manufacture, distribute or dispense controlled substances under sections 195.005 to 195.425 shall keep records and inventories of all such drugs in conformance with the recordkeeping and inventory requirements of federal law, and in accordance with any additional regulations of the department of health.

7.  Manufacturers and wholesalers shall keep records of all narcotic and controlled substances compounded, mixed, cultivated, grown, or by any other process produced or prepared, and of all controlled substances received and disposed of by them, in accordance with this section.

8.  Apothecaries shall keep records of all controlled substances received and disposed of by them, in accordance with the provisions of this section.

9.  The form of records shall be prescribed by the department of health.

195.100.  1.  It shall be unlawful to distribute any controlled substance in a commercial container unless such container bears a label containing an identifying symbol for such substance in accordance with federal laws.

2.  It shall be unlawful for any manufacturer of any controlled substance to distribute such substance unless the labeling thereof conforms to the requirements of federal law and contains the identifying symbol required in subsection 1 of this section.

3.  The label of a controlled substance in Schedule II, III or IV shall, when dispensed to or for a patient, contain a clear, concise warning that it is a criminal offense to transfer such narcotic or dangerous drug to any person other than the patient.

4.  Whenever a manufacturer sells or dispenses a controlled substance and whenever a wholesaler sells or dispenses a controlled substance in a package prepared by him, he shall securely affix to each package in which that drug is contained, a label showing in legible English the name and address of the vendor and the quantity, kind, and form of controlled substance contained therein.  No person except a pharmacist for the purpose of filling a prescription under sections 195.005 to 195.425, shall alter, deface, or remove any label so affixed.

5.  Whenever a pharmacist or practitioner sells or dispenses any controlled substance on a prescription issued by a physician, dentist, podiatrist, psychologist or veterinarian, he shall affix to the container in which such drug is sold or dispensed, a label showing his own name and address of the pharmacy or practitioner for whom he is lawfully acting; the name of the patient or, if the patient is an animal, the name of the owner of the animal and the species of the animal; the name of the physician, dentist, podiatrist, psychologist or veterinarian by whom the prescription was written; and such directions as may be stated on the prescription.  No person shall alter, deface, or remove any label so affixed.

195.110.  A person to whom or for whose use any controlled substance in Schedule II has been prescribed, sold, or dispensed by a physician, dentist, podiatrist, psychologist or pharmacist, or other person authorized under the provisions of section 195.050 and the owner of any animal for which any such drug has been prescribed, sold, or dispensed, by a veterinarian, may lawfully possess it only in the container in which it was delivered to him by the person selling or dispensing the same.

195.204.  1.  A person commits the offense of fraudulently attempting to obtain a controlled substance if he obtains or attempts to obtain a controlled substance or procures or attempts to procure the administration of the controlled substance by fraud, deceit, misrepresentation, or subterfuge; or by the forgery or alteration of a prescription or of any written order; or by the concealment of a material fact; or by the use of a false name or the giving of a false address.  The crime of fraudulently attempting to obtain a controlled substance shall include, but shall not be limited to nor be limited by, the following:

(1)  Knowingly making a false statement in any prescription, order, report, or record, required by sections 195.005 to 195.425;

(2)  For the purpose of obtaining a controlled substance, falsely assuming the title of, or representing oneself to be, a manufacturer, wholesaler, pharmacist, physician, dentist, podiatrist, psychologist, veterinarian, or other authorized person;

(3)  Making or uttering any false or forged prescription or false or forged written order;

(4)  Affixing any false or forged label to a package or receptacle containing controlled substances;

(5)  Possess a false or forged prescription with intent to obtain a controlled substance.

2.  Fraudulently attempting to obtain a controlled substance is a class D felony.

3.  Information communicated to a physician in an effort unlawfully to procure a controlled substance or unlawfully to procure the administration of any such drug shall not be deemed a privileged communication; provided, however, that no physician or surgeon shall be competent to testify concerning any information which he may have acquired from any patient while attending him in a professional character and which information was necessary to enable him to prescribe for such patient as a physician, or to perform any act for him as a surgeon.

4.  The provisions of this section shall apply to all transactions relating to narcotic drugs under the provisions of section 195.080, in the same way as they apply to transactions under all other sections.

195.400.  1.  As used in sections 195.400 to 195.425 the term "person" means any individual, corporation, government or governmental subdivision or agency, business trust, estate, trust, partnership or association, or any other legal entity.

2.  Any manufacturer, wholesaler, retailer, or other person who sells, transfers, or otherwise furnishes any of the following substances to any person shall submit to the department of health a report, as prescribed by the department of health, of all such transactions:

(1)  Anthranilic acid, its esters and its salts;

(2)  Benzyl cyanide;

(3)  Ergotamine and its salts;

(4)  Ergonovine and its salts;

(5)  N-Acetylanthranilic acid, its esters and its salts;

(6)  Phenylacetic acid, its esters and its salts;

(7)  Piperidine and its salts;

(8)  3,4,-Methylenedioxyphenyl-2-propanone;

(9)  Acetic anhydride;

(10)  Acetone;

(11)  Benzyl Chloride;

(12)  Ethyl ether;

(13)  Hydriodic acid;

(14)  Potassium permanganate;

(15)  2-Butanone (or Methyl Ethyl Ketone or MEK);

(16)  Toluene;

(17)  Ephedrine, its salts, optical isomers, and salts of optical isomers;

(18)  Norpseudoephedrine, its salts, optical isomers, and salts of optical isomers;

(19)  Phenylpropanolamine, its salts, optical isomers, and salts of optical isomers;

(20)  Pseudoephedrine, its salts, optical isomers, and salts of optical isomers;

(21)  Methylamine and its salts;

(22)  Ethylamine and its salts;

(23)  Propionic anhydride;

(24)  Isosafrole;

(25)  Safrole;

(26)  Piperonal;

(27)  N-Methylephedrine, its salts, optical isomers and salts of optical isomers;

(28)  N-Methylpseudoephedrine, its salts, optical isomers and salts of optical isomers;

(29)  Benzaldehyde;

(30)  Nitroethane;

(31)   Methyl Isobutyl Ketone (MIBK);

(32)  Sulfuric acid;

(33)  Iodine;

(34)  Red phosphorous.

3.  The chemicals listed or to be listed in the schedule in subsection 2 of this section are included by whatever official, common, usual, chemical, or trade name designated.

4.  The department of health by rule or regulation may add substances to or delete substances from subsection 2 of this section in the manner prescribed under section 195.017, if such substance is a component of or may be used to produce a controlled substance.

5.  Any manufacturer, wholesaler, retailer or other person shall, prior to selling, transferring, or otherwise furnishing any substance listed in subsection 2 of this section to a person within this state, require such person to give proper identification.  For the purposes of this section "proper identification" means:

(1)  A motor vehicle operator's license or other official state-issued identification which contains a photograph of the person and includes the residential or mailing address of the person, other than a post office box number;

(2)  The motor vehicle license number of any motor vehicle operated by the person;

(3)  A letter of authorization from the business to which any of the substances listed in subsection 2 of this section are being transferred, which shall include the address of the business and business license number if the business is required to have a license number;

(4)  A full description of how the substance is to be used; and

(5)  The signature of the person to whom such substances are transferred.  The person selling, transferring, or otherwise furnishing any substance listed in subsection 2 of this section shall affix his signature, to the document which evidences that a sale or transfer has been made, as a witness to the signature and proper identification of the person purchasing such substance.

6.  Any manufacturer, wholesaler, retailer, or other person who sells, transfers, or otherwise furnishes any substance listed in subsection 2 of this section to a person shall, not less than twenty-one days prior to the delivery of the substance, submit a report of the transaction as prescribed by the department of health, which shall include the proper identification information.  The department of health may allow the submission of such reports on a monthly basis with respect to repeated, regular transactions between a person who furnishes such substances and the person to whom such substances are delivered, if the department determines that either:

(1)  A pattern of regular supply of the substance exists between the manufacturer, wholesaler, retailer, or other person who sells, transfers, or otherwise furnishes such substance and the person to whom such substance is delivered; or

(2)  The person to whom such substance is delivered has established a record of utilization of the substance for lawful purposes.

7.  This section shall not apply to any of the following:

(1)  Any pharmacist, pharmacy, or other authorized person who sells or furnishes a substance listed in subsection 2 of this section upon the prescription or order of a physician, dentist, podiatrist, psychologist or veterinarian;

(2)  Any physician, optometrist, dentist, podiatrist, psychologist or veterinarian who administers, dispenses or furnishes a substance listed in subsection 2 of this section to his patients within the scope of his professional practice.  Such administration or dispensing shall be recorded in the patient record;

(3)  Any sale, transfer, furnishing or receipt of any drug which contains any substance listed in subsection 2 of this section and which is lawfully sold, transferred, or furnished over the counter without a prescription pursuant to the federal Food, Drug and Cosmetic Act [of] or regulations adopted thereunder.

8.  (1)  Any violation of subsection 5 of this section shall be a class D felony.

(2)  Any person subject to subsection 6 of this section who does not submit a report as required or who knowingly submits a report with false or fictitious information shall be guilty of a class D felony and subject to a fine not exceeding ten thousand dollars.

(3)  Any person who is found guilty a second time of not submitting a report as required in subsection 6 of this section or who knowingly submits such a report with false or fictitious information shall be guilty of a class C felony and subject to a fine not exceeding one hundred thousand dollars.

337.015.  1.  No person shall represent himself as a psychologist in the state of Missouri unless he is validly licensed and registered under the provisions of this chapter.  No person shall engage in the practice of psychology in the state of Missouri unless he is validly licensed and registered under the provisions of this chapter unless otherwise exempt under the provisions of sections 337.010 to 337.090.

2.  A person represents himself as a "psychologist" within the meaning of this chapter when he holds himself out to the public by any title or description of services incorporating the words "psychology", "psychological", or "psychologist", or any term of like import, "psychometry", "psychometrics", "psychometrist", "psychotherapy", "psychotherapists", "psychoanalysis", "psychoanalyst", or variants thereof or when the person purports to be trained, experienced or an expert in the field of psychology, and offers to render or renders services as defined below to individuals, groups, organizations, or the public for a fee, monetary or otherwise; provided, however, that professional counselors licensed to practice under this chapter, or a physician licensed to practice pursuant to chapter 334, RSMo, who specializes in psychiatry, may use any of such terms except "psychology", "psychological", or "psychologist" so long as such is consistent with their respective licensing laws.

3.  The "practice of psychology" within the meaning of this chapter is defined as the observation, description, evaluation, interpretation, treatment, and modification of human behavior by the application of psychological principles, methods, and procedures, for the purpose of preventing, treating, or eliminating symptomatic, maladaptive, or undesired behavior and of enhancing interpersonal relationships, work and life adjustment, personal effectiveness, behavioral health, and mental health.  The practice of psychology includes, but is not limited to, psychometric or psychological testing and the evaluation or assessment of personal characteristics, such as intelligence, personality, abilities, interests, aptitudes, and neuropsychological functioning; counseling, psychoanalysis, psychotherapy, hypnosis, biofeedback, and behavior analysis and therapy; diagnosis and treatment of mental and emotional disorder or disability in both inpatient and outpatient settings, alcoholism and substance abuse, disorders of habit or conduct, as well as the psychological aspects of physical illness, accident, injury, or disability; psychoeducational evaluation, therapy, remediation, and consultation; and teaching and training of psychological competence[.]; and prescribe drugs and other medications if the psychologist is certified by the committee to prescribe certain medications in the treatment of mental health disorders.  Psychological services may be rendered to individuals, families, groups, and the public.  The practice of psychology shall be construed within the meaning of this definition without regard to whether payment is received for services rendered.

4.  The application of these principles and methods includes, but is not restricted to: diagnosis, prevention, treatment, and amelioration of adjustment problems and emotional and mental disturbances of individuals and groups; hypnosis; counseling; educational and vocational counseling; personnel selection and management; the evaluation and planning for effective work and learning situations; advertising and market research; and the resolution of interpersonal and social conflicts.

337.053.  1.  The state committee of psychologists shall adopt reasonable rules and regulations providing for the examination and certification of licensed psychologists who apply to the committee for authority to prescribe drugs and other medications commonly used in the treatment of cognition, thinking, behavior and other mental health disorders.  Such drugs and medications shall be limited to those contained in a formulary of drugs as provided in subsection 5 of this section.

2.  No licensed psychologist shall prescribe any drug or medication in the practice of psychology unless such person submits to the state committee of psychologists evidence of satisfactory completion of a course of instruction in pharmacology which includes at least one hundred hours of approved clinical training under the direct supervision of a physician licensed pursuant to chapter 334, RSMo, and at least two hundred hours of independent course study in the assessment of the need for, and the prescription of, drugs in the treatment of persons with psychological problems and emotional and mental disorders and illnesses.

3.  In issuing a license pursuant to sections 337.010 to 337.093, the committee shall state upon the license of the psychologist whether the psychologist is certified to prescribe certain medications.

4.  The committee shall transmit the names of all psychologists that are certified to prescribe medications to the state board of pharmacy.  A pharmacist is authorized to fill any prescription written by a psychologist if the psychologist's name is on the list of those certified by the committee and the medication is an approved medication listed in the formulary which was adopted pursuant to subsection 5 of this section.

5.  The state committee of psychologists, the state board of registration for the healing arts and the board of pharmacy shall jointly promulgate rules establishing a formulary of drugs which may be prescribed by psychologists in systemic pathopsychology.

338.010.  1.  The "practice of pharmacy" shall mean the interpretation and evaluation of prescription orders; the compounding, dispensing and labeling of drugs and devices pursuant to prescription orders; the participation in drug selection according to state law and participation in drug utilization reviews; the proper and safe storage of drugs and devices and the maintenance of proper records thereof; consultation with patients and other health care practitioners about the safe and effective use of drugs and devices; and the offering or performing of those acts, services, operations, or transactions necessary in the conduct, operation, management and control of a pharmacy.  No person shall engage in the practice of pharmacy unless he is licensed under the provisions of this chapter.  This chapter shall not be construed to prohibit the use of auxiliary personnel under the direct supervision of a pharmacist from assisting the pharmacist in any of his duties.  This assistance in no way is intended to relieve the pharmacist from his responsibilities for compliance with this chapter and he will be responsible for the actions of the auxiliary personnel acting in his assistance.  This chapter shall also not be construed to prohibit or interfere with any legally registered practitioner of medicine, dentistry, podiatry, psychology, or veterinary medicine, or the practice of optometry in accordance with and as provided in sections 195.070 and 336.220, RSMo, in the compounding or dispensing of his own prescriptions.

2.  Nothing in this section shall be construed as to prevent any person, firm or corporation from owning a pharmacy regulated by sections 338.210 to 338.315, provided that a licensed pharmacist is in charge of such pharmacy.

3.  Nothing in this section shall be construed to apply to or interfere with the sale of nonprescription drugs and the ordinary household remedies and such drugs or medicines as are normally sold by those engaged in the sale of general merchandise.




Return to Main Bill Page

Return to Senate Home Page